Excalipoint Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Excalipoint Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Mar 18, 2026	Seed+	$27.7M	5Y Capital — Role not disclosedApricot Capital — Role not disclosedCenturium Capital — Role not disclosedEisai Innovation Inc — Role not disclosedLAV — Role not disclosedMPCi — Role not disclosed

Investors

5Y CapitalSeed+Apricot CapitalSeed+Centurium CapitalSeed+Eisai Innovation IncSeed+LAVSeed+MPCiSeed+

Coverage

Mar 18, 2026Excalipoint Therapeutics · Seed+

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

excalipoint.com ↗